These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 8528866)

  • 1. Immunotherapy in multiple sclerosis, Part 1.
    Becker CC; Gidal BE; Fleming JO
    Am J Health Syst Pharm; 1995 Sep; 52(18):1985-2000. PubMed ID: 8528866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy in multiple sclerosis, Part 2.
    Becker CC; Gidal BE; Fleming JO
    Am J Health Syst Pharm; 1995 Oct; 52(19):2105-20; quiz 2132-4. PubMed ID: 8535945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive treatment of multiple sclerosis.
    Carter JL; Rodriguez M
    Mayo Clin Proc; 1989 Jun; 64(6):664-9. PubMed ID: 2473360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic therapy for relapsing-remitting multiple sclerosis.
    MacLean HJ; Freedman MS
    Curr Neurol Neurosci Rep; 2001 May; 1(3):277-85. PubMed ID: 11898530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic therapy for secondary and primary progressive multiple sclerosis.
    Myers LW
    Curr Neurol Neurosci Rep; 2001 May; 1(3):286-93. PubMed ID: 11898531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer versus older treatments for relapsing-remitting multiple sclerosis.
    Weinstock-Guttman B; Cohen JA
    Drug Saf; 1996 Feb; 14(2):121-30. PubMed ID: 8852526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T; Bereczki D
    Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The peculiar difficulties of therapeutic trials for multiple sclerosis.
    Myers LW; Ellison GW
    Neurol Clin; 1990 Feb; 8(1):119-41. PubMed ID: 1690838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational clinical immunotherapy for multiple sclerosis.
    Hunter SF; Weinshenker BG; Carter JL; Noseworthy JH
    Mayo Clin Proc; 1997 Aug; 72(8):765-80. PubMed ID: 9276606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial.
    Massacesi L; Tramacere I; Amoroso S; Battaglia MA; Benedetti MD; Filippini G; La Mantia L; Repice A; Solari A; Tedeschi G; Milanese C
    PLoS One; 2014; 9(11):e113371. PubMed ID: 25402490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Insight: interferon treatment in multiple sclerosis.
    Marrie RA; Rudick RA
    Nat Clin Pract Neurol; 2006 Jan; 2(1):34-44. PubMed ID: 16932519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.
    Goodkin DE
    West J Med; 1994 Sep; 161(3):292-8. PubMed ID: 7975569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of multiple sclerosis therapy in Germany: a national survey.
    Heesen C; Hauer S; Hadji-Abdolrahim B; Berenbeck C; Buhmann C; Emskotter T
    Eur J Neurol; 1999 Jan; 6(1):35-8. PubMed ID: 10209347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is new in the treatment of multiple sclerosis?
    Weinstock-Guttman B; Jacobs LD
    Drugs; 2000 Mar; 59(3):401-10. PubMed ID: 10776827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis: a review of existing therapy and future prospects.
    Khan OA
    J Pak Med Assoc; 1996 Jan; 46(1):20-4. PubMed ID: 8830165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of multiple sclerosis: the state of the art.
    Karussis D
    BioDrugs; 2013 Apr; 27(2):113-48. PubMed ID: 23423844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
    Cazzato G; Antonello RM; Zorzon M; Torre P; Zivadinov R; Moretti R; Bragadin LM; De Masi R; Nasuelli D
    Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
    Stuart WH
    Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort.
    Kalincik T; Horakova D; Dolezal O; Krasensky J; Vaneckova M; Seidl Z; Havrdova E
    Clin Neurol Neurosurg; 2012 Sep; 114(7):940-6. PubMed ID: 22402204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.